Financial News Feed

Previous Hold Today VKTXW ranks #3493 as HOLD CANDIDATE. Next Hold
Today VKTXW ranks #3493 as HOLD CANDIDATE.

VKTXW stock VKTXW

VKTXW stock
VKTXW

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Viking Therapeutics (VKTX) and Spectrum ... The post Analysts’ Top Healthcare Picks: Viking Therapeut...

Read more

Viking Therapeutics, Inc. (NASDAQ:VKTX) has recently been spotted approaching 52-week highs. Investors may be following how the stock price reacts as it nears this level. At the time of writing, compa...

Read more

Investors may be tracking sell-side analyst opinions on shares of Viking Therapeutics, Inc. (NASDAQ:VKTX). According to analysts polled by Zacks Research, the current consensus target price is $28.07....

Read more

Viking Therapeutics Stock Regains Ground
06:40pm, Thursday, 17'th Jan 2019
Viking Therapeutics fell earlier this week after Citron Research released a bearish report on licensor Ligand Pharma, but shares recovered on Thursday....

Read more

Shares of Ligand Pharmaceuticals (LGND) took a beating on Wednesday after a bearish report by Citron Research led by short-seller Andrew Left criticized the company…...

Read more

The Value Composite Two of Viking Therapeutics, Inc. (NasdaqCM:VKTX) is 73. The VC2 is calculated using the price to book value, price to sales, EBITDA to EV, price to cash flow, price to earnings and...

Read more

Investors may be studying recent technical signals on shares of Viking Thera (VKTX). Watching the longer-term MACD oscillator indicator, we have seen that the signal is Sell. The MACD is typically use...

Read more

The Money Flow Indicator for Viking Thera (VKTX) has touched above 60 and has found a place on investor’s radar as it potentially nears the key 70 mark. The MFI indicator is an oscillator which rang...

Read more

Research brokerage firms on Wall Street are offering a consensus “Buy” rating on shares of Viking Therapeutics, Inc. (NASDAQ:VKTX). Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 ...

Read more

Shares of Viking Thera (VKTX) have been tilting lower over the past 13 weeks, revealing bearish momentum for the shares, as they have dipped -46.00% over the past quarter. Looking further out we note ...

Read more

Placing Straumann Holding AG (SWX:STMN) shares under the microscope we note that the firm has a current Return on Equity of 0.240882. Simply put, this ratio determines how well the firm uses investmen...

Read more

A market scorned for clinical-stage biotech stocks tore a big chunk from this NASH drug developer....

Read more

Viking Thera (VKTX) shares have moved below the Chalkin Money Flow zero line, indicating potential bearish momentum for the shares. The Chaikin Money Flow Indicator is an oscillator developed by Marc ...

Read more

Atlantia S.p.A. (BIT:ATL) currently has a current ratio of 1.63. The current ratio, which is also known as the working capital ratio, is a liquidity ratio that displays the proportion of current asset...

Read more

The clinical-stage biotech hopes to tap into what could be a megablockbuster indication....

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank